PMID: 6536939Nov 1, 1984Paper

Annoyance and irritation by passive smoking

Preventive Medicine
A Weber

Abstract

The acute irritating and annoying effects of smoke have been investigated in field and laboratory studies by examining the concentration of some smoke components in air. In the workplace, 30 to 70% of the indoor carbon monoxide, nitrogen oxide, and particulate concentrations are due to tobacco smoke; 25-40% of the employees are disturbed and/or annoyed by smoke and 25% suffer from eye irritation at work. Subjective eye, nose, and throat irritations and eye blink rate increase with increasing smoke concentration and increasing exposure duration. Irritation is due mainly to the particulate phase of environmental tobacco smoke, whereas the gas phase is, to a large extent, responsible for annoyance. It is concluded that healthy individuals can tolerate an environmental tobacco smoke level that corresponds to a carbon monoxide concentration of 1.5 to 2.0 ppm. Above these limits, countermeasures to protect passive smokers are necessary. In order not to exceed the upper tolerable threshold limit of 2.0 ppm carbon monoxide, it is necessary to have a fresh air supply of 33 m3 per hour per cigarette smoked. Special attention should be paid to groups of people with increased sensitivity to environmental tobacco smoke, e.g., asthmatics, al...Continue Reading

References

Dec 1, 1979·Environmental Research·R J ShephardF Silverman
Mar 1, 1968·Archives of Environmental Health·F Speer
Jun 1, 1982·American Journal of Public Health·S L GortmakerH Ruch-Ross
Nov 1, 1981·Chest·T E DahmsR G Slavin
Jan 1, 1980·International Archives of Occupational and Environmental Health·A Weber, T Fischer

❮ Previous
Next ❯

Citations

Jan 1, 1987·Toxicology Letters·D HoffmannK D Brunnemann
Jan 1, 1987·Toxicology Letters·I O'Neill, E Riboli
Jun 23, 1998·Survey of Ophthalmology·Y SolbergM Belkin
Nov 20, 1997·The New England Journal of Medicine·D Menzies, J Bourbeau
Dec 1, 2000·The Pediatric Infectious Disease Journal·K S KakishA Daoud
Apr 30, 1992·Annals of the New York Academy of Sciences·B BerglundS Nordin
Sep 6, 2012·Tobacco Control·Benjamin J ApelbergPatrick N Breysse
Feb 1, 1989·American Journal of Public Health·J C ByrdD L Schiedermayer
Jun 13, 2006·American Journal of Ophthalmology·Dilek Dursun AltinorsKazuo Tsubota
Oct 24, 2013·Cutaneous and Ocular Toxicology·Nihat SayinHasan Altinkaynak
Jan 1, 1991·Journal of Toxicology. Clinical Toxicology·B O BrooksR D Schimke
Jan 10, 1998·Journal of Occupational and Environmental Medicine·M C WillemsenM L Vos de Wael
Mar 31, 2010·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Samantha K WardKazuo Tsubota
Jun 1, 1992·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·B W JafekP M Eller
Dec 23, 2016·Journal of Ophthalmology·Ali M MasmaliGamal A El-Hiti
Jan 1, 1987·Sozial- Und Präventivmedizin·A HartmannB Danuser
Jun 1, 1992·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·D A Leopold
Mar 1, 2020·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Dimitra MakryniotiGeorge Lagoumintzis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Franz H GrusNorbert Pfeiffer
Korean Journal of Ophthalmology : KJO
Kyung-Chul YoonMan-Seong Seo
Journal of Toxicology and Environmental Health. Part a
I DurakH S Oztürk
© 2021 Meta ULC. All rights reserved